SCHEMBL17509827

SCHEMBL17509827

COc1cccc2c(C)cc(=O)n(C)c12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 9/20 1.00
▸ CYP19A1 P11511 8/20 1.00
▸ MAPT P10636 2/20 0.56
▸ KDM4E B2RXH2 3/20 0.53
▸ ALDH1A1 P00352 2/20 0.51
▸ HPGD P15428 2/20 0.51
▸ GLA P06280 1/20 0.50
▸ GAA P10253 1/20 0.50
▸ CASP1 P29466 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ CASP7 P55210 1/20 0.50
▸ ATM Q13315 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ MAPK1 P28482 1/20 0.49
▸ BLM P54132 1/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ JAK2 O60674 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17509824 0.83 CYP19A1 (0.70) NQO2CYP19A1MAPTKDM4EALDH1A1
SCHEMBL12559800 0.82 NQO2 (0.70) NQO2CYP19A1MAPTKDM4EALDH1A1
SCHEMBL17509826 0.80 CYP19A1 (0.66) NQO2CYP19A1MAPTKDM4EALDH1A1
SCHEMBL11217793 0.78 MAPT (0.67) NQO2CYP19A1MAPTKDM4EALDH1A1
SCHEMBL11503490 0.78 NQO2 (0.64) NQO2CYP19A1MAPTKDM4EALDH1A1
SCHEMBL20650932 0.78 CYP19A1 (0.62) NQO2CYP19A1MAPTKDM4EALDH1A1
SCHEMBL14438070 0.76 CYP19A1 (0.61) NQO2CYP19A1MAPTKDM4EALDH1A1
SCHEMBL21067704 0.76 CYP19A1 (1.00) NQO2CYP19A1MAPTKDM4EALDH1A1
SCHEMBL22271826 0.75 CYP19A1 (0.60) NQO2CYP19A1MAPTKDM4EALDH1A1
SCHEMBL14873828 0.75 CYP19A1 (0.77) NQO2CYP19A1MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160257651-A1 NOVEL COMPOUND WITH ANTIBACTERIAL ACTIVITY JUNTENDO EDUCATIONAL FOUNDATION (JP) 2016-09-08 — — US disclosed
EP-2987787-A1 NOVEL COMPOUND WITH ANTIBACTERIAL ACTIVITY Juntendo Educational Foundation (JP) 2016-02-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160257651-A1 NOVEL COMPOUND WITH ANTIBACTERIAL ACTIVITY SLC11A2, RELA, NFKBIA NQO2 23/4885CYP19A1 3596/4885MAPT 3675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback